(secondQuint)EXecutive Registry: Evaluating XIENCE V in a Multi Vessel Disease.

 This is a clinical evaluation of the XIENCE V(R) everolimus eluting coronary stent system as a revascularization treatment of patients with multi-vessel coronary artery disease (MVD-CAD).

 The sutdy is composed of two parts: A Randomized Controlled Trial, outlined in a separate posting and the registry portion of this study, which is as follows: -A prospective controlled registry to analyze the clinical efficacy and safety at mid and long-term follow-up in patients with MVD treated with the XIENCE V(R) Everolimus Eluting Coronary Stent System (XIENCE V(R) EECSS).

.

 EXecutive Registry: Evaluating XIENCE V in a Multi Vessel Disease@highlight

The purpose of this two part study is the assessment of the performance of the XIENCE V(R) Everolimus Eluting Coronary Stent System (XIENCE V(R) EECSS) in the treatment of the specific setting of patients with Multi-Vessel Coronary Artery Disease (MVD).

